🔗 Share this article

Chancellor Reeves has revealed she is preparing "focused action to address cost of living challenges" in next month's Budget.

Speaking to media outlets, she emphasized that lowering inflation is a collective task of both the government and the central bank.

The UK's price growth is expected to be the highest among the Group of Seven industrialized countries this year and next.

Potential Utility Bill Interventions

Reports indicate the government could intervene to lower energy bills, for instance by reducing the current 5% level of value-added tax charged on energy.

An additional possibility is to reduce some of the regulatory levies presently included in bills.

Budgetary Constraints and Analyst Expectations

The government will receive the next draft from the official forecaster, the OBR, on the start of the week, which will show how much space there is for such measures.

The view from most analysts is that the Chancellor will have to announce higher taxes or budget cuts in order to fulfill her voluntary borrowing rules.

Earlier on the same day, estimates indicated there was a twenty-two billion pound shortfall for the chancellor to fill, which is at the more modest range of expectations.

"There's a collective responsibility between the central bank and the administration to bear down further on some of the sources of price increases," Reeves stated to the BBC in the US capital, at the yearly gatherings of the International Monetary Fund and global financial institution.

Tax Pledges and Global Issues

While a great deal of the attention has been on likely tax rises, the Treasury chief said the latest data from the fiscal watchdog had not changed her commitment to election pledges not to raise tax levels on income tax, VAT or social security contributions.

She blamed an "unpredictable global environment" with rising international and trade concerns for the fiscal revenue measures, likely to be targeted on those "wealthiest."

International Economic Disputes

Commenting on apprehensions about the United Kingdom's trade ties with China she said: "Our security interests invariably are paramount."

Recent announcement by Chinese authorities to strengthen export controls on critical minerals and other materials that are essential for high-technology production led US President the US President to suggest an further 100% import tax on imports from China, raising the prospect of an full-scale trade war between the two largest economies.

The American finance chief called China's move "economic coercion" and "a international production power grab."

Questioned on accepting the US offer to join its dispute with the Asian nation, the Chancellor said she was "deeply worried" by China's measures and called on the Chinese government "to avoid restrictions and restrict access."

She said the move was "harmful for the global economy and creates further headwinds."

"In my view there are sectors where we should address China, but there are also valuable prospects to export to Chinese markets, including financial services and other sectors of the economic system. We've got to maintain that equilibrium correct."

The chancellor also stated she was cooperating with other major economies "on our own essential resources strategy, so that we are reduced dependence."

Health Service Medicine Pricing and Investment

Reeves also acknowledged that the price the National Health Service pays for medicines could rise as a result of current talks with the US government and its pharmaceutical firms, in return for reduced taxes and funding.

Some of the biggest global pharmaceutical manufacturers have said recently that they are either halting or canceling operations in the United Kingdom, with some attributing the insufficient payments they are obtaining.

Last month, the government science advisor said the cost the health service spends on drugs would have to rise to stop businesses and pharmaceutical investment departing from the United Kingdom.

Reeves stated to media: "We have seen because of the cost structure, that medical research, recent pharmaceuticals have not been offered in the UK in the manner that they are in other European countries."

"We want to ensure that people receiving care from the NHS are able to access the best essential drugs in the world. And so we are examining these issues, and... looking to obtain more funding into Britain."